Canton Strategic Holdings, Inc. (CNTN)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network. It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton Coin (CC) on a customer's behalf while retaining legal and beneficial ownership. In addition, the company invests in the Canton ecosystem. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is based in New York, New York.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
Canton Strategic Holdings, Inc. has not issued a press release in this window.
SEC filings
All filings →Canton Strategic Holdings, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Canton Strategic Holdings, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for Canton Strategic Holdings, Inc. in this window.
People at Canton Strategic Holdings, Inc.
All people →No officers or directors have been indexed for Canton Strategic Holdings, Inc..